BiologicalDrug
Fibrinolysin clinical trials
Also written Plasmin, TAL-05-00018 and BAY-57-9602.
Keep track of what changes. Save the Fibrinolysin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Grifols Therapeutics LLC (3) · Bausch & Lomb Incorporated (2) · Christian Haslinger (1)
Related medicines
As reviewed, each with the page that says it.
- One of Fibrinolytic Agents source
Studies
Open first, then newest update. How each study uses Fibrinolysin is read from its arms, and is right about nine times in ten.
Testing it · 6
- SWIFT - SWIss Factor XIII Trial in PPHRecruitingPhase 4Christian HaslingerNCT06481995Written as Fibrogammin
- A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)TerminatedPhase 1/2Bausch & Lomb IncorporatedNCT00347646Written as Plasmin
- Study to Evaluate Plasmin for the Creation of a Posterior Vitreous DetachmentTerminatedPhase 2Bausch & Lomb IncorporatedNCT00348439Written as Plasmin
- A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial OcclusionCompletedPhase 2Grifols Therapeutics LLCNCT01222117Written as Plasmin
- A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft OcclusionCompletedPhase 1Grifols Therapeutics LLCNCT00418483Written as Plasmin (Human) 25 mg
- A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke PatientsCompletedPhase 1/2Grifols Therapeutics LLCNCT01014975Written as Plasmin (Human)
Codes
What other systems call Fibrinolysin · ClinicalTrials.gg INT007489
- MeSH (NLM) D005341FibrinolysinOne source ClinicalTrials.gov
- UNII (FDA) D60E3WIF5YFIBRINOLYSIN (HUMAN)One source FDA
- RxNorm 4388One source FDA
- NCI Thesaurus C180643Fibrinolysin HumanOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005341 | Fibrinolysin | One source ClinicalTrials.gov |
| UNII (FDA) | D60E3WIF5Y | FIBRINOLYSIN (HUMAN) | One source FDA |
| RxNorm | 4388 | — | One source FDA |
| NCI Thesaurus | C180643 | Fibrinolysin Human | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.